Once the 25-day post-IPO quiet period ended in early July 2026, major brokerages began coverage with mostly buy-equivalent ratings. The targets I reviewed include Raymond James' Brian Gesuale at $800 (Strong Buy); Morgan Stanley's Adam Jonas at $300; Deutsche Bank's Edison Yu at $255; JPMorgan's Doug Anmuth at $225; RBC Capital Markets at $225; Goldman Sachs' Eric Sheridan at $205; Citi's John Godyn at $200; a neutral view from MoffettNathanson at $131; and a sell-side view from CFRA at $115. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Across these nine targets, the arithmetic mean is about $273, rounded to a $270 central target. The median sits near $250, and roughly 14 of the initial 19 initiations clustered between $200 and $250. Broader aggregations that include more analysts place the average near $233, underscoring how the $800 outlier pulls the mean higher. Analysts generally cite Starlink, launch dominance, and Starship as the bull case, while bears flag valuation and cash-burn concerns.
The shares have trended lower since their July highs, recently trading around $126, below the $135 IPO price. Reaching $270 from that level implies roughly 114% upside, a very large move by any standard. The path would likely require sustained Starlink subscriber growth, progress on Starship's orbital economics, and steady execution against revenue expectations — Wall Street anticipated third-quarter 2026 revenue near $12.9 billion, with some estimates projecting full-year revenue in the $22–30 billion range.
SpaceX's Falcon 9 completed 165 launches in 2025, accounting for more than 90% of global payload mass to orbit, while Starlink has grown past 10 million subscribers across 160-plus countries. The company completed Starship's first orbital flight in late September 2026, and Cathie Wood's ARK Invest added to its position. Nasdaq-100 inclusion in July 2026 also brought passive demand. These factors, if sustained, could underpin revenue and EBITDA growth.
Valuation remains a central concern: even after the pullback, the stock trades on a high price-to-sales (P/S) multiple relative to traditional aerospace and technology peers, and the company continues to invest heavily. Lockup expirations could add supply, and all 12 lead underwriters carry buy ratings, a uniformity some observers see as a potential conflict. Slower Starlink growth, Starship setbacks, or a broad market rotation away from high-multiple growth stocks could all cap the shares.
The $135 IPO price now acts as overhead resistance after the decline below it, followed by the $150–$160 post-listing highs. On the downside, the recent lows near $126 and the round $100 level mark important support zones. Until the stock reclaims $135 with conviction, the technical structure remains challenged.
Analyst price targets generally reflect a 12-month research horizon, though the initiation notes reviewed here span a very wide range of outcomes. Investors should monitor quarterly earnings and EPS results, Starlink subscriber and revenue figures, Starship milestones, lockup expirations, and any analyst target revisions. Macroeconomic conditions and interest-rate expectations also matter for a high-multiple growth name.
In my own work, I often turn to Tickeron’s AI Daily Buy/Sell Signals to monitor SPCX alongside other names. The tool applies artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical behavior and market shifts. It helps me spot changes more efficiently while I continue my own analysis.
The $270 target represents the arithmetic mean of nine verified analyst price targets, with a median near $250 and a range from about $115 to $800. Reaching $270 would require a very large gain of roughly 114% from recent levels near $126. The bull case rests on Starlink scale, launch dominance, and Starship's potential, while valuation, cash burn, lockup supply, and a skeptical minority of analysts present the main obstacles. The outcome will depend on execution against those growth expectations, and no single target should be treated as a forecast.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
SPCX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on October 13, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 57 instances where the indicator turned negative. In 24 of the 57 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 42%.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SPCX as a result. In 33 of 123 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 27%.
SPCX moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for SPCX crossed bearishly below the 50-day moving average on October 27, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 29%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SPCX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 28%.
The Aroon Indicator for SPCX entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 9 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
SPCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 9 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: SPCX's P/B Ratio (13.912) is slightly higher than the industry average of (5.050). SPCX has a moderately low P/E Ratio (-122.064) as compared to the industry average of (17.247). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.110). Dividend Yield (0.000) settles around the average of (0.055) among similar stocks. P/S Ratio (69.444) is also within normal values, averaging (18.367).
The Tickeron Price Growth Rating for this company is 34 (best 1 - 100 worst), indicating steady price growth. SPCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 37 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 61 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense